Compare GEF & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEF | MMED |
|---|---|---|
| Founded | 1877 | 1983 |
| Country | United States | United States |
| Employees | 15660 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.7B |
| IPO Year | 1994 | 2025 |
| Metric | GEF | MMED |
|---|---|---|
| Price | $70.71 | $18.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 16 |
| Target Price | ★ $85.60 | $25.33 |
| AVG Volume (30 Days) | 319.4K | ★ 8.6M |
| Earning Date | 11-03-2026 | 11-24-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $5,448,100,000.00 | $3,102,000,000.00 |
| Revenue This Year | $1.08 | $10.76 |
| Revenue Next Year | $2.12 | $8.51 |
| P/E Ratio | $4.09 | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $59.91 | $10.65 |
| 52 Week High | $90.57 | $24.43 |
| Indicator | GEF | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 24.43 | 47.68 |
| Support Level | $69.35 | $16.61 |
| Resistance Level | $70.84 | $20.40 |
| Average True Range (ATR) | 2.74 | 0.95 |
| MACD | -0.96 | 0.02 |
| Stochastic Oscillator | 1.34 | 45.31 |
Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.